Nicotine receptor partial agonists are medications that help people stop smoking by modulating brain chemistry. They work by maintaining moderate dopamine levels to reduce withdrawal symptoms and decreasing the satisfaction derived from smoking.
This update of a comprehensive review provides insights into how these drugs can support tobacco dependence treatment, highlighting their potential benefits and mechanisms.